Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member. Inc (PCLN), OpenTable Inc (OPEN) – Innovating On Everyday Tasks: Pet Medicine, Flights & Restaurant Bookings

Page 1 of 2

Nothing is more rewarding than good, cheap-to-execute ideas. There are not many of them, but when they appear, someone will surely make a profit. Petmed Express Inc (NASDAQ:PETS), Inc (NASDAQ:PCLN), and OpenTable Inc (NASDAQ:OPEN) have made successful businesses out of good ideas that didn’t need hefty initial capital investments. Let’s take a look at how these Internet-based firms accomplished their success and what their future prospects look like now. Inc (NASDAQ:PCLN)

My pet’s pharmacist is online

Last week a drone delivered its first pizza. The event got little press, but has left an important mark on the delivery business. PetMed has not gone as far, or at least not yet. Nevertheless, by breaking the monopoly held by veterinarians, the firm set a trend in the pet medicine business. So far it has dominated market competition while maintaining solid finances. Prospects are so good for the company that researchers are dismissive of negative analysis.

Although total revenues fell in 2013 year-over-year, this decline was the result of two external and temporal factors (unavailable Novartis brand and abnormal seasonal temperatures). If Novartis does not resume production, Petmed Express Inc (NASDAQ:PETS) will only be saved by veterinarians changing preferred brands. Such a way out of this dilemma is possible, and is already on the works with ever more medicines losing its patents. Given the firm’s early entry at a low price and successful growth story, no significant competition is expected soon. Moreover,  the company’s last earnings report has proven its increasing value.

PetMed’s expected growth rates are mainly based on three factors: the real-state market recovery, the pet medicine industry (pushed by generic brands), and the expansion of electronic commerce. Now that the planets have aligned, the company needs to market the event. To do this, management will need to start spending some real bucks since elections in the U.S. have resulted in a strong upsurge on prime-time advertising price. The alternative to hefty marketing investments is letting the customer makes its own move, given that there is no serious market competition. Whatever decision management takes with marketing, the firm will continue to profit thanks to the four catalysts mentioned above.

Yes, PetMed will be around for a while and has proven itself to possess sound management that is preoccupied with making a profit for themselves and the company’s shareholders. The company has never been in a better shape than now, and it is trading cheap carrying mid-to-high teens earnings year-to-year. For the aforementioned reasons, you should buy this stock as the company´s short and long-term prospects look promising.

Booking with Captain Kirk

Sometimes one wonders how partnerships are built. How did Inc (NASDAQ:PCLN) convince James Kirk to become “The Negotiator?” Only they know. Regardless, the company has found and sustained great success. Its achievements have allowed it to repurchase shares, keep reasonable debt levels, and find various roads to growth. That is an enjoyable combination. Inc (NASDAQ:PCLN) is no stranger to innovation. It has offered customers great bargains for some time now, and its finances have remained balanced even with growing competition. A great deal of its success amid its competition is the direct result of managerial decisions. Domestic and foreign acquisitions and expansion have given the company an important edge over lagging competitors which mostly focus on the domestic arena.

Europe was Inc (NASDAQ:PCLN)’s first venture abroad and provided positive results. As Internet penetration deepened, disposable income increased, and online flight booking became popular in Asia and Latin America, the firm was able to expand into new markets and stay one step ahead of the competition. This advantage has been reflected in increasing revenues, cash flow, and free cash. Inc (NASDAQ:PCLN) is a great buy, but its price is high. If you have the bucks to invest, go ahead. This is a company with happy management and shareholders, and it has plenty of remaining potential for expansion and profit.

Making reservations at Dorsia possible

Not having a reservation at a local restaurant for your long-awaited date will subtract brownie points. With OpenTable Inc (NASDAQ:OPEN) becoming widely available, making reservations should not be an issue any longer. Investing in the company, however, is a different and more complicated issue to address.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!